用镁合金促进兵器装备轻量化

概述了兵器装备轻量化的意义、镁合金的性能特点 ,介绍了镁合金在兵器上应用的实例 ,指出了镁合金在兵器上应用存在的问题 ,分析了镁合金在兵器上应用的前景 ,对镁合金在兵器上的应用工作提出了若干建议     

Flow sorting of fetal erythroblasts using intracytoplasmic anti-fetal haemoglobin: Preliminary observations on maternal samples

Monoclonal antibody to fetal haemoglobin (a₂γy₂) has been proposed as a fetal-specific reagent. We developed an intracellular staining protocol that combines fluorescein isothiocyanate or phycoerythrin conjugated anti-γ with the DNA binding dye Hoechst 33342 to identify and flow sort fetal erythroblasts from maternal blood. Our preliminary observations on anti-γ-positive cells sorted from four different pregnant women are described here, using fluorescence in situ hybridization (FISH) with chromosome-specific probes to identify fetal cells. Our data demonstrate that far fewer candidate fetal cells are sorted with this protocol than by current cell surface staining methods that employ the monoclonal antibody CD71. This results in increased fetal cell sorting purities. With this protocol, standard FISH techniques require modification due to the rigorous fixation with 4 per cent paraformaldehyde. Our initial data indicate the promise of this approach.     

Effects of mid-trimester induced abortion on the subsequent pregnancy

The outcome of the pregnancy following (a) a mid-trimester termination of pregnancy (TOP) for fetal neural tube defect (NTD) (77 women=group 1); (b) mid-trimester TOP for fetal Down's syndrome (13 women=group 2); (c) delivery of a baby with NTD (119 women=group 3) was studied. The prenatal fetal loss was relatively high in all groups. In group 1 it was similar to that found in other studies after first trimester TOP, in group 2 it was associated with advanced maternal age and the unexpected finding in group 3 was not attributable to advanced maternal age. It is suggested that a previous NTD per se might increase the risk of fetal loss in the next pregnancy. A previous mid-trimester TOP for NTD was not associated with an increase in premature labour, small for dates babies or congenital abnormality in the next pregnancy, but there was a slight increase in the number of babies weighing less than 2500 g.     

有机物对UF膜过滤通量的影响

采用截留分子量为30000的聚醚砜超滤膜进行膜过滤试验,研究有机物的特性,如亲疏水性以及相对分子质量对超滤膜通量的影响.试验结果表明,过滤亲水性组分时膜通量明显高于过滤疏水性组分.对2种不同水源的试验表明,尽管有机物含量相同,但由于亲疏水性的比例不同,造成的膜通量下降不同.疏水性越大的原水,其膜通量下降也越大.因此,疏水性组分是造成通量下降的主要因素.试验还表明,相对分子质量较大的有机物并非通量下降的主要因素,有机物的分散性可能是影响通量的主要因素.     

GA优化的湖泊富营养化评价的普适公式探讨

在适当设定富营养化指标的“本底值”情况下,当指标值用于对应“本底值”的相对值表示时,可采用S型曲线描述湖泊富营养化的发展程度,公式中的参数可视为与指标特性无关,采用遗传算法对公式参数优化,得到对多项指标均适用的富营养化程度的指数公式,并提出用广义模糊对比因子赋权新方法计算富营养化综合指数。该评价方法物理意义明确,计算简单,使用方便,具有普适性、可比性和实用性。     

水中天然有机物的臭氧强化光催化降解研究

研究了饮用水源中大分子天然有机物（NOM）的臭氧强化光催化降解,考察了臭氧投加量、反应时间和HCO3^-浓度对NOM降解速率的影响;分析了臭氧强化光催化过程中NOM相对分子质量的变化,并比较不同相对分子质量大小NOM的降解速率.研究结果表明,臭氧强化光催化比单独臭氧氧化、光催化能更有效地降解NOM,同时增加臭氧投加量和反应时间才能有效提高臭氧强化光催化对TOC的去除率,而单独增加臭氧投加量可显著提高生物可降解性;HCO3^-显著降低光催化的降解效果,臭氧强化光催化能有效地减弱HCO3^-的不利影响;臭氧强化光催化过程中大分子NOM分解为小分子,SUVA值迅速下降,且相对分子质量越大矿化速度越快.     

Detection of fetal HLA-DQα sequences in maternal blood: A gender-independent technique of fetal cell identification

The objective of this study was to detect fetal HLA-DQα gene sequences in maternal blood. HLA-DQα genotypes of 70 pregnant women and their partners were determined for type A1. We specifically sought couples where the father, but not the mother, had genotype A1. In 12 women, maternal blood samples were flow-sorted. Candidate fetal cells were isolated and amplified by using PCR primers specific for a paternal HLA-DQα A1 allele. Fetal HLA-DQα A1 genotype was predicted from sorted cells; amniocytes or cheek swabs were used for confirmation. Six of twelve sorted samples had amplification products indicating the presence of the HLA-DQα A1 allele; 6/12 did not. Prediction of the fetal genotype was 100 per cent correct, as determined by subsequent amplification of amniocytes or cheek swabs. We conclude that paternally inherited uniquely fetal HLA-DQα gene sequences can be identified in maternal blood. This system permits the identification of fetal cells independent of fetal gender, and has the potential for non-invasive prenatal diagnosis of paternally inherited conditions.     

Maternal age-specific risks for trisomies at 9—14 weeks' gestation

This study provides data on the incidence of fetal trisomies 21, 18, and 13 at 9–14 weeks' gestation in women aged 35–45 years and estimates of maternal age-specific risks in women aged 20–45 years. Our data from 5814 singleton pregnancies undergoing first-trimester karyotyping for the sole indication of maternal age ⩾ 35 years were combined with those from two previous reports and the incidence of the trisomies was calculated from a total of 15 793 pregnancies. Comparison of incidences at 9–14 weeks' gestation with published data at 15–20 weeks' gestation and in livebirths demonstrated that at birth the maternal age-specific incidence of trisomy 21 is 33 per cent lower than at 15–20 weeks' gestation and 54 per cent lower than at 9–14 weeks' gestation. Furthermore, the relative frequency of trisomies 18 and 13 decreases from 30 per cent at 9–14 weeks to 22 per cent at 15–20 weeks and 14 per cent at birth.     

Dystrophin protein and rflp analyis for fetal diagnosis and carrier confirmation of duchenne muscular dystrophy

A pregnant woman with indeterminate Duchenne muscular dystrophy (DMD) carrier status, but with DMD diagnosed in her deceased brother (unavailable for study), presented for prenatal diagnosis, intending to continue the pregnancy only if proven unaffected with DMD with near absolute certainty. Creatine kinase (CK) assays to clarify carrier status were inconclusive. Male sex in the fetus was identified, but DNA restriction fragment length polymorphism (RFLP) analysis was not yet available to this centre to investigate the possible transmission of the DMD gene, and the pregnancy was terminated. Tissue histology and dystrophin protein analysis demonstrated the absence of DMD. In a situation with proven maternal carrier status, future fetal inheritance of the opposite maternal X chromosome would indicate the presence of DMD. However, maternal carrier status remained in doubt through a second pregnancy, even with RFLP studies, and was finally established when dystrophin analysis confirmed the presence of DMD in the second fetus. Histologic findings are presented, contrasting features in the two fetuses. The value of dystrophin analysis for establishing the diagnosis of fetal DMD, in this case proving maternal carrier status in a difficult situation, and for demonstrating DMD gene:RFLP haplotype relationships is illustrated.     

Prenatal diagnosis of endocardial fibroelastosis

In a case of fetal heart failure caused by endocardial fibroelastosis, prenatal echocardiography clearly demonstrated; a thickened endocardium. We therefore suggest that an abnormal endocardium may be detected in utero by ultrasound, thus representing an important clue in the differential diagnosis of fetal nonimmune hydrops and in the evaluation of pregnancies at risk for endocardial fibroelastosis.